The liver plays a central role in Sermorelin’s mechanism of action, serving as the primary organ where growth hormone exerts its metabolic effects. GH release is inhibited by somatostatin, free fatty acids, and insulin-like growth factor 1 (IGF-1). These factors work together to ensure your body has enough GH throughout the day without releasing too much and causing serious side effects. In adults, GH is released and binds to receptors in the liver to increase the production of IGF-1.
Unlike exogenous rhGH that causes production of the bioactive hormone IGF-1 from the liver, sermorelin simulates the patients own pituitary gland by binding to specific receptors to increase production and secretion of endogenous hGH.
This natural stimulation of the liver’s IGF-1 production pathway represents a safer approach to growth hormone optimization compared to direct hormone replacement. The liver responds to circulating growth hormone by producing IGF-1, which then mediates many of the beneficial effects throughout the body.
HGH causes the liver to secrete a hormone known as IGF-1. The metabolic effects of this hormone are well-known. Fats stored in the form of triglycerides are broken down and converted into energy.5
By enhancing the liver’s capacity to process and metabolize fats, Sermorelin therapy supports hepatic health and reduces the metabolic burden on this vital organ. The improved triglyceride breakdown helps prevent fatty liver conditions associated with metabolic dysfunction.
Growth hormone deficiency causes lower resting metabolism, but the sermorelin peptide therapy invigorates the metabolism, reversing this state. This therapy increases protein synthesis, increases oxidation of fat, reduces LDL or harmful cholesterol, and normalizes carbohydrate metabolism. These effects consequently improve body composition and heart health.
The reduction in LDL cholesterol and normalization of carbohydrate metabolism directly benefits liver function, as the liver is responsible for cholesterol synthesis and glucose regulation. By optimizing these processes, Sermorelin helps maintain hepatic efficiency.
Individuals with Severe Liver or Kidney Disease: Impaired liver or kidney function can affect the metabolism and clearance of Sermorelin, increasing the risk of side effects.
It’s important that individuals with pre-existing liver conditions consult with healthcare providers before initiating Sermorelin therapy, as compromised hepatic function may affect how the peptide is processed.
GH plays an important role in regulating body composition, bone and muscle growth, fat metabolism, and sugar and lipid (fat) metabolism. GH also helps to maintain the health of organs and tissues throughout the body.
The comprehensive metabolic support provided by optimized growth hormone levels extends to liver health, helping maintain this organ’s crucial functions in detoxification, protein synthesis, and metabolic regulation.
IGF-1 also impacts fibroblast function (cell formation), which tells the body to release enzymes to break up and remove dead skin, then manufacture collagen to replace it with new skin.
While this primarily refers to skin function, the same fibroblast-stimulating effects of IGF-1 support tissue regeneration throughout the body, including the liver’s capacity for self-repair and cellular renewal.
